Home › Funds › Two Sigma Investments › FRLN
Two Sigma Investments position in FRLN
FREELINE THERAPEUTICS HLDGS
Latest position (Q1 2023)43.01K sh
Reported value held$19.57K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 85.96K | $293.00K | New |
| Q4 2021 | 41.07K | $81.00K | Reduce |
| Q1 2022 | 132.82K | $149.00K | Add |
| Q2 2022 | 68.04K | $59.00K | Reduce |
| Q3 2022 | 50.91K | $36.00K | Reduce |
| Q4 2022 | 43.60K | $20.72K | Reduce |
| Q1 2023 | 43.01K | $19.57K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.